Alphatec Holdings is trading at $7.69, up 9.23%, amid improving market sentiment; no clear company-specific catalyst was found. - On November 2, the Nasdaq was up 0.72% and the Dow was up 0.82%. - Its latest earnings report cited a revenue miss and reduced 2026 guidance after weaker biologics attachment, factors associated with the prior-session selloff. - The market recovery follows a recent tech-led selloff, but available evidence does not establish a direct cause for the unusually large rebound.